Neon Bloom Signs Letter of Intent to Acquire Advanced Executive Sales, LLC - Seite 2
Greg Bauer, AES Founder and Managing Member, said, "AES is eager to scale our talent, resources, experience and customer base and, with the structure of this "marriage", joining forces with NBCO makes AES part of a publicly held company which allows access for the combined company to sources of working capital - equity and debt - that AES has not been able to access as a privately-held enterprise".
About Neon Bloom:
Neon Bloom, Inc. (OTC PINK:NBCO) is a diversified enterprise group, currently engaged in the development of new life-science technologies, technologically improved financial services, and other
emerging business sectors. Beginning in 2020 NBCO began to expand its leadership team and its investments in new acquisitions; in 2021 it acquired Bazelet Health Systems, Inc. ("Bazelet") in an
all-stock transaction, and currently operates Bazelet as a wholly owned subsidiary. The Company intends to make additional acquisitions in the near future utilizing shares of its common stock,
non-convertible promissory performance-based notes, and cash as available.
About Bazelet Health Systems, Inc:
Bazelet, is the licensed US plant patent, trademark, and manufacturer of PAN2020, the world's first patented cannabis plant (US Plant Patent number US PP32,725 P2). PAN2020 is a new and distinct
variety of cannabis sativa (L.) plant and contains 0.00% tetrahydrocannabinol (THC), making it the first and only federally legal cannabis plant. With Pan2020, Bazelet developed the proprietary
ingredient PECSA (Plant-based EndoCannabinoid System Activator), used in the manufacturing and commercial supply of food, drug, and cosmetic products that comply with the Food, Drug and Cosmetic
Act. There are no health care claims being made by the Company or Bazelet about the PECSA products; these products are not intended to treat, diagnose, mitigate, prevent, or cure diseases, nor do
they have any therapeutic effect as to any specific medically diagnosed conditions.
CONTACT:
Shareholder Relations
E-MAIL: shholders@directequitysource.com
TELEPHONE 1- 888-404-3314
Lesen Sie auch
Forward-Looking Statements:
This press release includes "forward-looking statements", that involve risks and uncertainties. All statements other than statements of historical facts, included in this press release that address
activities, events, or developments that we expect or anticipate will or may occur in the future, including such things as future capital expenditures (including the amount and nature thereof),
business strategy and measures to implement strategy, competitive strength, goals, expansion and growth of our business and operations, plans, references to future success, reference to intentions
as to future matters, and other such matters are forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as "may," "will," "should," "expects,"
"plans," "anticipates," "believes," "estimates," "predicts," "potential," or "continue," or the negative of such terms or other comparable terminology. These statements are only predictions. Actual
events or results may differ materially. These statements are based upon certain assumptions and analyses made by us considering our experience and our perception of historical trends, current
conditions and expected future developments as well as other factors that we believe are appropriate in the circumstances. However, whether actual results and developments will conform to our
expectations and predictions is subject to several risks, uncertainties, and other factors, many of which are beyond our control. Although we believe that the expectations reflected in the
forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance, or achievements. Moreover, we do not assume responsibility for the accuracy and
completeness of such forward-looking statements. We are under no duty to update any of the forward-looking statements after the date of this release to confirm such statements to actual results.